Skip to main navigation
  • Careers
  • Partnerships & Business Development
  • Contact Us
Link to  Esperion Therapeutics, Inc. Homepage
  • Company
    • About Us
    • Leadership Team
    • Board of Directors
    • Ethics and Compliance
    • Corporate Governance & Committee Composition
  • Products
  • Science
    • Unmet Need
    • Scientific Resources
    • Scientific Advisory Board
    • Pipeline
    • Grants
  • Investors & Media
    • Overview
    • Newsroom
    • Events
    • Financial Information
    • Stock Information & Analyst Coverage
    • FAQs

Investor Relations

Latest News

Apr 02, 2026
Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)
Mar 31, 2026
Esperion to Participate in 25th Annual Needham Virtual Healthcare Conference
View All News

Latest Quarterly Earnings Results

Results

  • Fourth Quarter and Full Year 2025 Financial Results
  • Esperion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
  • Esperion Q4 & Full Year 2025 Earnings Presentation 2 MB
  • Form 10-K

Corporate Presentation

ESPR Company Presentation - March 2026 6.6 MB

Investor Events

Upcoming Events

More events are coming soon.

Past Events

Apr 13, 2026 9:30 AM EDT
25th Annual Needham Virtual Healthcare Conference
Mar 11, 2026 8:25 AM EDT
The 2026 Citizens Life Sciences Conference
View All Events
Last Price
Volume
Apr 12, 2026 1:06 AM EDT | Minimum 15 minutes delayed. Source: LSEG
  • OUR COMPANY
  • About Us
  • Leadership Team
  • Board of Directors
  • Ethics and Compliance
  • Corporate Governance & Committee Composition
  • PRODUCTS
  • SCIENCE
  • Unmet Need
  • Scientific Resources
  • Scientific Advisory Board
  • Pipeline
  • Grants
  • CAREERS
  • Partnerships & Business Development
  • INVESTORS & MEDIA
  • Overview
  • Newsroom
  • Events
  • Financial Information
  • Stock Information & Analyst Coverage
  • FAQs
  • Contact Us
Great place to work certified | JUN 2024 - JUN 2025 | USA

All trademarks and trade names are the property of their respective owners.

© 2026 Esperion Therapeutics, Inc. All rights reserved.

  • Privacy Policy
  • Terms of Use
  • Accessibility Statement
  • Social Media Community Guidelines
  • facebook
  • instagram
  • linkedin
  • twitter
  • rss
Search Investors